Clinical Trials
17 trialsNCT06221774 2024-01-24
Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2 Unknown
NCT05576961 2024-01-23
Safety and Efficacy of RX-af01 Combined With PD-1 Antibody
Sun Yat-sen University
Phase 1/2 Unknown
NCT05580445 2023-11-22
Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer
Shouyao Holdings (Beijing) Co. LTD
Phase 1/2 Unknown
NCT05723432 2023-04-27
KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced Melanoma
Shanghai Kanda Biotechnology Co., Ltd.
Phase 1/2 Unknown
NCT04856631 2022-12-19
A Study of Toripalimab Injection (JS001) + Cetuximab in Treatment of Advanced Head and Neck Squamous Cell Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 1/2 Unknown
NCT03864211 2022-09-29
Thermal Ablation Followed by Immunotherapy for HCC
Xiangya Hospital of Central South University
Phase 1/2 Unknown
NCT05341193 2022-04-22
PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 1/2 Unknown
NCT04058470 2022-04-14
Toripalimab Plus Rituximab Followed by R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma
Sun Yat-sen University
Phase 1/2 Unknown
NCT02915432 2021-12-13
The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC
Shanghai Junshi Bioscience Co., Ltd.
Phase 1/2 Unknown
NCT05103917 2021-11-02
A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC
Abbisko Therapeutics Co, Ltd
Phase 1/2 Unknown
NCT04988191 2021-08-03
Toripalimab Plus Bevacizumab and Chemotherapy as Neoadjuvant Therapy in Advanced MSI-H or dMMR Colorectal Cancer
Peking University
Phase 1/2 Unknown
NCT04926532 2021-06-15
Toripalimab
Shanghai Zhongshan Hospital
Phase 1/2 Unknown
NCT04337463 2021-05-17
ATG-008 Combined With Toripalimab in Advanced Solid Tumors
Sichuan University
Phase 1/2 Unknown
NCT04797702 2021-03-15
CT32
Shanghai Junshi Bioscience Co., Ltd.
Phase 1/2 Unknown
NCT04368273 2020-04-29
CCRT+PD-1
Peking University Third Hospital
Phase 1/2 Unknown
NCT04069949 2019-10-25
STUHCCPVTT
Sichuan University
Phase 1/2 Unknown
NCT04061928 2019-08-20
Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ
Peking University
Phase 1/2 Unknown